Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Psychopharmacology|May 1, 1997
A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawalR F Anton, H R Kranzler, J P McEvoy, et al.
Comprehensive Psychiatry|January 1, 1989
Why must some schizophrenic patients be involuntarily committed? The role of insightJ P McEvoy, P S Applebaum, L J Apperson, et al.
Psychiatry Research|February 17, 1998
Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illnessJ H Gilmore, L F Jarskog, J C Lindgren, et al.
The Journal of Clinical Psychiatry|March 1, 1982
Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical studyJ P McEvoy, J Libiger, W H Wilson, et al.
The Journal of Clinical Psychiatry|February 9, 2000
Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patientsR M Hirschfeld, M H Allen, J P McEvoy, et al.
The Journal of Nervous and Mental Disease|December 1, 1995
Insight in schizophrenia and maniaC L Swanson, O Freudenreich, J P McEvoy, et al.
Psychopharmacology|March 1, 1996
A randomized, controlled, dose-ranging trial of sertindole in patients with schizophreniaD P van Kammen, J P McEvoy, S D Targum, et al.
The American Journal of Psychiatry|December 1, 1996
Response of patients with treatment-refractory schizophrenia to clozapine within three serum level rangesC VanderZwaag, M McGee, J P McEvoy, et al.
The American Journal of Psychiatry|May 1, 1987
Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteersJ P McEvoy, M McCue, B Spring, et al.
The Journal of Nervous and Mental Disease|January 1, 1989
Insight and the clinical outcome of schizophrenic patientsJ P McEvoy, S Freter, G Everett, et al.
Pageof 6